Top 10 Books about Stock Investing to read in 2018. Read more.

INFI - Infinity Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

INFI - Infinity Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Fri 15'th Jun 2018

PERIOD 2018-03-16 - 2018-06-15
CHANGE 6.98%
PRICE $1.84





Request Prediction

Infinity Pharmaceuticals Stock Analysis

Technical stock analysis for Fri 15'th Jun 2018

Sell candidate since 2018-06-01 Loss -8.46%

Infinity Pharmaceuticals gained 6.98% in the last trading day, rising from $1.72 to $1.84 The price has fallen in 6 of the last 10 days and is down by -8.46% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 414 more shares were traded than the day before. In total, 546 483 shares bought and sold for approximately $0.00.

Shorts 4.19% ( 2018-05-31 )
Cash 121.8 mill
Loans n/a
Beta 2.38
ROA -48.05


Infinity Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.95% during the next 3 months and, with 90% probability hold a price between $1.28 and $1.74 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Thursday June 14, 2018, which indicates further gains until a new top pivot has been found. Infinity Pharmaceuticals has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Infinity Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.01. On a fall, the stock will find some support from the short-term average at $1.83. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 40 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Infinity Pharmaceuticals finds support from accumulated volume at $1.82.

Support: $1.82 Price: $1.84 Resistance: $1.85


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.14 between high and low, or 8.24%. For the last week, the stock has had a daily average volatility of 6.61%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Infinity Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Trade INFI CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features